The Correlation Between Clostridium-difficile Infection and Human Gut Concentrations of Bacteroidetes Phylum and Clostridial Species

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 2013 Sep 20

PMID 24048726

Citations 22

Authors

E Goldberg

I Amir

M Zafran

U Gophna

Z Samra

S Pitlik

J Bishara

Affiliations

Soon will be listed here.

Abstract

We aimed to assess differences in bacterial intensities of Bacteroidetes phylum and different clostridial species in the human intestines with respect to C. difficile infection. Patients with a stool assay for C. difficile toxin were identified via the microbiology laboratory in our institute. Bacterial populations were quantified from stool samples of four groups of patients: Group I-patients with C. difficile associated diarrhea (CDAD); Group II-asymptomatic C. difficile carriers; Group III-patients with non-C. difficile diarrhea; Group IV-patients with no diarrhea and negative stool samples for the C. difficile toxin (control group). Stool was examined for three genes-C. difficile toxin A gene, 16S rRNA gene from Clostridium thermocellum representing other clostridial species, and 16S rRNA gene from Bacteroides fragilis representing the Bacteroidetes phylum. Fifty-nine patients underwent analysis of the stool (CDAD group 14, carriers group 14, non-C. difficile diarrhea group 16, control group 15). C. difficile concentration was highest in the CDAD group, followed by the carriers group. Higher concentrations of both clostridial species and Bacteriodetes were observed in the control and non-C. difficile diarrhea groups compared to the CDAD and carriers groups. We demonstrated an inverse association between infection with C. difficile and the abundance of Bacteroidetes phylum and other clostridial species in human intestines. Studies with larger samples and broader diagnostic procedures are needed in order to better explore and understand this association.

Citing Articles

Diabetes and gut microbiome.

Fliegerova K, Mahayri T, Sechovcova H, Mekadim C, Mrazek J, Jarosikova R Front Microbiol. 2025; 15():1451054.

PMID: 39839113 PMC: 11747157. DOI: 10.3389/fmicb.2024.1451054.

Understanding Quorum-Sensing and Biofilm Forming in Anaerobic Bacterial Communities.

Markowska K, Szymanek-Majchrzak K, Pituch H, Majewska A Int J Mol Sci. 2024; 25(23).

PMID: 39684519 PMC: 11641729. DOI: 10.3390/ijms252312808.

Dual RNA-seq study of the dynamics of coding and non-coding RNA expression during infection in a mouse model.

Kreis V, Toffano-Nioche C, Deneve-Larrazet C, Marvaud J, Garneau J, Dumont F mSystems. 2024; 9(12):e0086324.

PMID: 39601557 PMC: 11651100. DOI: 10.1128/msystems.00863-24.

Microbial ecology between and gut microbiota.

Kamiya S Biosci Microbiota Food Health. 2023; 42(4):229-235.

PMID: 37791342 PMC: 10542429. DOI: 10.12938/bmfh.2023-033.

The role of the gut microbiome in colonization resistance and recurrent infection.

Seekatz A, Safdar N, Khanna S Therap Adv Gastroenterol. 2022; 15:17562848221134396.

PMID: 36425405 PMC: 9679343. DOI: 10.1177/17562848221134396.

References

Van Der Waaij D . Evidence of immunoregulation of the composition of intestinal microflora and its practical consequences. Eur J Clin Microbiol Infect Dis. 1988; 7(1):103-6. DOI: 10.1007/BF01962193. View

Sullivan A, Edlund C, Nord C . Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis. 2002; 1(2):101-14. DOI: 10.1016/S1473-3099(01)00066-4. View

Vickerman M, Brossard K, Funk D, Jesionowski A, Gill S . Phylogenetic analysis of bacterial and archaeal species in symptomatic and asymptomatic endodontic infections. J Med Microbiol. 2006; 56(Pt 1):110-118. DOI: 10.1099/jmm.0.46835-0. View

Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A . Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol. 2004; 97(6):1166-77. DOI: 10.1111/j.1365-2672.2004.02409.x. View

Belanger S, Boissinot M, Clairoux N, Picard F, Bergeron M . Rapid detection of Clostridium difficile in feces by real-time PCR. J Clin Microbiol. 2003; 41(2):730-4. PMC: 149705. DOI: 10.1128/JCM.41.2.730-734.2003. View

Mazmanian S, Round J, Kasper D . A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008; 453(7195):620-5. DOI: 10.1038/nature07008. View

Sambol S, Merrigan M, Tang J, Johnson S, Gerding D . Colonization for the prevention of Clostridium difficile disease in hamsters. J Infect Dis. 2002; 186(12):1781-9. DOI: 10.1086/345676. View

Kelly C, Pothoulakis C, Lamont J . Clostridium difficile colitis. N Engl J Med. 1994; 330(4):257-62. DOI: 10.1056/NEJM199401273300406. View

Manges A, Labbe A, Loo V, Atherton J, Behr M, Masson L . Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J Infect Dis. 2010; 202(12):1877-84. DOI: 10.1086/657319. View

10.

Borody T, Warren E, Leis S, Surace R, Ashman O, Siarakas S . Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol. 2004; 38(6):475-83. DOI: 10.1097/01.mcg.0000128988.13808.dc. View

11.

McFarland L, Mulligan M, Kwok R, Stamm W . Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989; 320(4):204-10. DOI: 10.1056/NEJM198901263200402. View

12.

Kyne L, Warny M, Qamar A, Kelly C . Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000; 342(6):390-7. DOI: 10.1056/NEJM200002103420604. View

13.

Boyanton Jr B, Sural P, Loomis C, Pesta C, Gonzalez-Krellwitz L, Robinson-Dunn B . Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection. J Clin Microbiol. 2011; 50(3):640-5. PMC: 3295153. DOI: 10.1128/JCM.01014-11. View

14.

Warny M, Vaerman J, Avesani V, Delmee M . Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun. 1994; 62(2):384-9. PMC: 186119. DOI: 10.1128/iai.62.2.384-389.1994. View

15.

Rousseau C, Levenez F, Fouqueray C, Dore J, Collignon A, Lepage P . Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition. J Clin Microbiol. 2010; 49(3):858-65. PMC: 3067754. DOI: 10.1128/JCM.01507-10. View

16.

Merrigan M, Sambol S, Johnson S, Gerding D . Prevention of fatal Clostridium difficile-associated disease during continuous administration of clindamycin in hamsters. J Infect Dis. 2003; 188(12):1922-7. DOI: 10.1086/379836. View

17.

Hopkins M, Macfarlane G . Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol. 2002; 51(5):448-454. DOI: 10.1099/0022-1317-51-5-448. View

18.

Mazmanian S, Liu C, Tzianabos A, Kasper D . An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005; 122(1):107-18. DOI: 10.1016/j.cell.2005.05.007. View

19.

WILSON K . The microecology of Clostridium difficile. Clin Infect Dis. 1993; 16 Suppl 4:S214-8. DOI: 10.1093/clinids/16.supplement_4.s214. View